NCT05521256 - A Research Study of a New Medicine NNC0113-6856 in Healthy Males | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 26, 2022

Primary Completion Date

March 27, 2023

Study Completion Date

March 27, 2023

Conditions

Healthy VolunteersType 2 Diabetes

Interventions

DRUG

NNC0113-6856

Participants will receive NN0113-6856 orally or intravenously.

DRUG

Placebo

Participants will receive matching placebo of NNC0113-6856 for each of the oral cohorts.

Trial Locations (2)

Profil Institut für Stoffwechselforschung GmbH, Neuss